Synthesis and evaluation of tripeptidyl α-Ketoamides as human rhinovirus 3C protease inhibitors
暂无分享,去创建一个
Beverly A. Heinz | Shu-Hui Chen | B. Heinz | Q. Wang | Robert B. Johnson | Jason Eric Lamar | Frantz Victor | Nancy June Snyder | Mark Wakulchik | Q. May Wang | N. Snyder | M. Wakulchik | J. Lamar | F. Victor | Shuhui Chen
[1] B. Heinz,et al. Glutamine-derived aldehydes for the inhibition of human rhinovirus 3C protease , 1995 .
[2] E. Hébert,et al. Maximum optical rotation of 2-fluorooctane? A survey of fluorinating reagents , 1979 .
[3] D. Barton,et al. A new method for the deoxygenation of secondary alcohols , 1975 .
[4] D. Le-Nguyen,et al. PyBOP®: A new peptide coupling reagent devoid of toxic by-product , 1990 .
[5] J. Monn,et al. A Concise, Stereocontrolled Thiazolium Ylide Approach to Kainic Acid , 1994 .
[6] P. Dragovich. Recent advances in the development of human rhinovirus 3C protease inhibitors , 2001 .
[7] N. Roehm,et al. An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. , 1991, Journal of immunological methods.
[8] D. Matthews,et al. Tripeptide aldehyde inhibitors of human rhinovirus 3C protease: design, synthesis, biological evaluation, and cocrystal structure solution of P1 glutamine isosteric replacements. , 1998, Journal of medicinal chemistry.
[9] D. Matthews,et al. Structure-based design of ketone-containing, tripeptidyl human rhinovirus 3C protease inhibitors. , 2000, Bioorganic & medicinal chemistry letters.
[10] M. Xian,et al. S-nitrosothiols as novel, reversible inhibitors of human rhinovirus 3C protease. , 2000, Bioorganic & medicinal chemistry letters.
[11] S. Venkatraman,et al. Design, synthesis, and evaluation of azapeptides as substrates and inhibitors for human rhinovirus 3C protease. , 1999, Bioorganic & medicinal chemistry letters.
[12] D. Norbeck,et al. Inhibition of 3C protease from human rhinovirus strain 1B by peptidyl bromomethylketonehydrazides. , 1999, Archives of biochemistry and biophysics.
[13] D. Matthews,et al. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P1 lactam moieties as L-glutamine replacements. , 1999, Journal of medicinal chemistry.
[14] D. Matthews,et al. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 3. Structure-activity studies of ketomethylene-containing peptidomimetics. , 1999, Journal of medicinal chemistry.
[15] A. Porter. Picornavirus nonstructural proteins: emerging roles in virus replication and inhibition of host cell functions , 1993, Journal of virology.
[16] R. Loncharich,et al. A continuous colorimetric assay for rhinovirus-14 3C protease using peptide p-nitroanilides as substrates. , 1997, Analytical biochemistry.
[17] D. Dess,et al. Readily accessible 12-I-5 oxidant for the conversion of primary and secondary alcohols to aldehydes and ketones , 1983 .
[18] S. Venkatraman,et al. Synthesis and evaluation of peptidyl Michael acceptors that inactivate human rhinovirus 3C protease and inhibit virus replication. , 1998, Journal of medicinal chemistry.
[19] A. El‐Faham,et al. The diisopropylcarbodiimide/ 1-hydroxy-7-azabenzotriazole system: Segment coupling and stepwise peptide assembly , 1999 .
[20] D. Matthews,et al. Structure of human rhinovirus 3C protease reveals a trypsin-like polypeptide fold, RNA-binding site, and means for cleaving precursor polyprotein , 1994, Cell.
[21] T. Shepherd,et al. Small peptidic aldehyde inhibitors of human rhinovirus 3C protease , 1996 .